Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cosmos Health Inc (COSM)

Cosmos Health Inc (COSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,938
  • Shares Outstanding, K 23,260
  • Annual Sales, $ 53,380 K
  • Annual Income, $ -18,540 K
  • EBIT $ -19 M
  • EBITDA $ -18 M
  • 60-Month Beta 5.57
  • Price/Sales 0.23
  • Price/Cash Flow N/A
  • Price/Book 0.57
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.48
  • Most Recent Earnings $-0.45 on 11/14/24
  • Next Earnings Date 11/19/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 311.40% ( -23.24%)
  • Historical Volatility 101.38%
  • IV Percentile 61%
  • IV Rank 20.78%
  • IV High 1,368.20% on 02/07/24
  • IV Low 34.13% on 07/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 181
  • Volume Avg (30-Day) 71
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,659
  • Open Int (30-Day) 2,049

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -190.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5100 +51.22%
on 01/13/25
1.0500 -26.55%
on 01/21/25
+0.1883 (+32.30%)
since 12/20/24
3-Month
0.5100 +51.22%
on 01/13/25
1.0500 -26.55%
on 01/21/25
+0.0188 (+2.50%)
since 10/22/24
52-Week
0.4677 +64.89%
on 04/22/24
1.5800 -51.19%
on 08/21/24
-0.2388 (-23.64%)
since 01/22/24

Most Recent Stories

More News
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...

COSM : 0.7712 (-17.08%)
Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

CHICAGO, IL / ACCESS Newswire / January 21, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative...

COSM : 0.7712 (-17.08%)
Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D,...

COSM : 0.7712 (-17.08%)
Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

CHICAGO, IL / ACCESSWIRE / December 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D,...

COSM : 0.7712 (-17.08%)
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

CHICAGO, IL / ACCESSWIRE / December 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D,...

COSM : 0.7712 (-17.08%)
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price

CHICAGO, IL / ACCESSWIRE / November 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D,...

COSM : 0.7712 (-17.08%)
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D,...

COSM : 0.7712 (-17.08%)
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

CHICAGO, IL / ACCESSWIRE / July 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner...

COSM : 0.7712 (-17.08%)
MarketBeat: Week in Review 11/28 – 12/02

Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week

JD : 39.12 (+1.61%)
BBY : 83.92 (-0.72%)
ZM : 79.28 (+0.94%)
OGI : 1.5700 (+1.95%)
COSM : 0.7712 (-17.08%)
AAPL : 223.83 (+0.53%)
SOFI : 17.59 (-1.73%)
NIO : 4.28 (+2.39%)
XPEV : 14.53 (-3.13%)
QSR : 60.54 (-0.33%)
DPZ : 442.12 (+0.30%)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk

Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment

COSM : 0.7712 (-17.08%)
GME : 27.65 (+0.66%)
AMC : 3.39 (-2.59%)
PFE : 26.01 (-2.36%)
GSK : 33.43 (-1.04%)
AZN : 68.20 (+0.35%)

Business Summary

Cosmos Health is a healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices. Cosmos Health, formerly known as Cosmos Holdings Inc., is based in CHICAGO, IL.

See More

Key Turning Points

3rd Resistance Point 1.1934
2nd Resistance Point 1.0693
1st Resistance Point 0.9203
Last Price 0.7712
1st Support Level 0.6472
2nd Support Level 0.5231
3rd Support Level 0.3741

See More

52-Week High 1.5800
Fibonacci 61.8% 1.1551
Fibonacci 50% 1.0238
Fibonacci 38.2% 0.8926
Last Price 0.7712
52-Week Low 0.4677

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar